Finance newsletter earnings, ranked by estimated MRR
Public revenue estimates for tracked finance newsletters.
| Rank | Publication | MRR | ARR | YoY |
|---|
Public revenue estimates for tracked finance newsletters.
| Rank | Publication | MRR | ARR | YoY |
|---|

Tracked Publication
I research and share thesis-driven ideas on potential healthcare multibaggers. Not financial advice.
Earnings Estimates (Gross MRR)
Subscriber Composition
Revenue Estimates (Gross MRR)
$3.4KRange $1.7K – $5.2K
Free Subscribers
3KPaid Subscribers (est.)
52Post Activity
4 posts/moMedian Engagement per Post
Reactions
6
over 25 posts
Comments
0
over 25 posts
Restacks
1
over 25 posts
Paid Plans
Included in all plans
Recent Posts
We initiated at $24 in January. It fell to $18 by March. MIMEDX is now buying it at $35. Closing the book on the position, and on a trade that went the wrong way first.

Trading Below Cash Again, But Half the Business Has Been Sold

A microcap turnaround at the inflection point, with a partner-funded pipeline attached at no cost, in a stock still priced on the old story.

A boring, profitable compounder with 18% share of a market that is only growing.